Trials / Conditions / Ras (Kras or Nras) Gene Mutation

Ras (Kras or Nras) Gene Mutation

5 registered clinical trials studyying Ras (Kras or Nras) Gene Mutation — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors NCT06326411	Nested Therapeutics, Inc	Phase 1
Recruiting	Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer NCT06449989	Blokhin's Russian Cancer Research Center	—
Terminated	Study of IK-595 in RAS- or RAF-altered Advanced Tumors NCT06270082	Ikena Oncology	Phase 1
Recruiting	Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations NCT06229340	N.N. Petrov National Medical Research Center of Oncology	Phase 2
Recruiting	CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) NCT04151342	University Health Network, Toronto	—